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Background: Cardiac computed tomography angiography (CTA) is feasible for aortic valve evaluation, but
retrospective gated protocols required high radiation doses for aortic valve assessment. A prospectively triggered
adaptive systolic (PTAS) cardiac CT protocol was recently described in arrhythmia using second-generation
dual-source CT. In this study, we sought to evaluate the feasibility of PTAS CTA to assess the aortic valve at a low
radiation dose.
Findings: A retrospective cohort of 29 consecutive patients whom underwent PTAS protocols for clinical
indications other than aortic valve assessment and whom also received echocardiography within 2 months of CT,
was identified. Images were reviewed for aortic valve morphology (tricuspid/bicuspid/prosthetic) and stenosis (AS)
by experienced blinded readers. Accuracy versus echocardiography and radiation doses were assessed.
All PTAS coronary CTAs were clinically diagnostic with 0 un-evaluable coronary segments. The accuracy of PTAS for
aortic valve morphology was 92.6%, and for exclusion of severe AS was 93.1%. Two exams were un-evaluable for
the aortic valve due to inadequate number of phases archived for interpretation. Total radiation dose was a median
of 2.8 mSv (interquartile range 1.4–4.4 mSv).
Conclusions: PTAS CTA protocols using second-generation dual-source CT for aortic valve evaluation are feasible at
low doses. This protocol should be investigated further in larger cohorts.
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Prospectively ECG-triggered cardiac CT angiography
targeted to end-systole for the evaluation of aortic path-
ology was feasible at a low radiation dose (2.8 mSv) with
128 dual-source CT.Introduction
The feasibility of cardiac computed tomography angiog-
raphy (CTA) for aortic valvular evaluation has been
established for aortic stenosis (AS) evaluation (via direct* Correspondence: AMSHLEE@HOTMAIL.COM
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reproduction in any medium, provided the orplanimetry) in small referral cohorts [1-9], and has
performed well versus transthoracic echocardiography. All
initially published studies were performed using retro-
spective ECG gating to allow systolic phase evaluation of
aortic valve opening [10,11]. Retrospective ECG gating is
widely available but involves significant radiation dose ex-
pense versus prospective triggering and is now used infre-
quently [12,13].
Various refinements to prospective triggering algo-
rithms such as arrhythmia rejection are available
[13-15]. Recently, the use of a systolic target for pro-
spective triggering was described as a means to miti-
gate variable and elevated heart rates [16-18]; this
method was applied using late-generation dual-source. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Patient characteristics
Patients characteristics and scan parameters n = 29
Age 64.1 ± 16.6
Male 18 (62.1%)
Mean heart rate (bpm) 66.4 ± 10.9
Heart rate variability (bpm) 39.9 ± 35.6
Rhythm during scan
Sinus rhythm 19 (65.5%)
Atrial fibrillation 7 (24.1%)
Other (atrial flutter, etc.) 3 (10.3%)
Contrast amount (cc) 96.1 ± 13.9
Flow rate (cc/sec) 6.0 ± 2.8
Beta blocker used 17 (58.6%)
BMI 24.9 ± 4.6
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to specify an acquisition in systole after the R-peak,
and a fixed range of data acquisition to enable various
reconstruction intervals to achieve motion-free images.
This method limits imaging to mid and late systole,
phases shown to be ideal for aortic valve area opening
measurements [19].
Because this protocol may allow aortic valve analysis
(valve morphology and AS), we evaluated its feasibility ver-
sus echocardiography. We hypothesized that prospectively
triggered adaptive systolic images (PTAS) would allow ad-
equate aortic valve evaluation at a significantly decreased
radiation dose versus retrospectively ECG-gated images
(6.7 to 20 mSv in one meta-analysis) [11].
Technical methods
Our institutional IRB (The Partners Human Research
Committees) granted a waiver for this retrospective re-
search. HIPAA compliance was maintained throughout
the study. No outside funding was received, and the au-
thors maintained full control over the data.
Patient population
This retrospective study included 29 patients who under-
went clinically indicated CTA with PTAS from December
2011 to August 2012. All patients underwent echocardiog-
raphy within two months of CTA.
Data acquisition
All exams were performed on a second-generation dual
source 128-slice CT scanner (SOMATOM Definition
Flash, Siemens Medical Systems with software update
VA40, Forchheim, Germany). A gantry rotation time of
280 milliseconds (msec) yielded a temporal resolution
of 75 msec. Sublingual nitroglycerin (0.6 mg) was given
unless contraindicated (i.e. known aortic stenosis at theFigure 1 ECG strip demonstrating timing of image acquisition.
PTAS CTA is shown with radiation exposure peak at 100% of the
reference tube current (red arrow, “Range” settings) at 300–400 msec
and a “plateau” (green arrow, “Scan” settings) with 20% of the
reference tube current to capture additional phases at mid and late
systole/early diastole.time of CT scan). Beta-blocker (metoprolol IV) was ad-
ministered per physician discretion when necessary.
Contrast was delivered (Iopamidol 370 g/cm3, Isovue
370, Bracco Diagnostics, Princeton, NJ USA) via power
injector per clinical routine. An automatic tube poten-
tial selection with tube current modulation algorithm
[20,21] was used to minimize radiation dose while
maintaining diagnostic image contrast-to-noise ratio.
The PTAS protocol was executed with a positive abso-
lute delay of 300–400 msec after the R peak (100%
mAs exposure, Figure 1) with widened window acquisi-
tion (20% mAs, 200–300 msec and 400–450 msec).
Arrhythmia rejection algorithm (Adaptive Cardio Se-
quence, “Adaptive Cardio Sequential Flex mode”, Sie-
mens Medical Systems, Forchheim, Germany) was
enabled in all scan acquisition. This arrhythmia rejec-
tion algorithm compensated for gradual changes in
heart rate and allowed scan positions to be immediately
repeated in the case of an ectopic or widely irregular
beat.Image reconstruction and analysis
Raw data were reconstructed at multiple phases of R-R
interval (300 msec, 350 msec, 375 msec, 400 msec, and/
or as clinically necessary). For each phase archived in
PACS, images were reconstructed in multiplanar re-
formatted axes to obtain a series of short axis view
through the aortic valve.Radiation exposure
Volume CT dose index (CTDIvol) and dose length prod-
uct (DLP) for the CTA scans were recorded and effective
dose was calculated [12].
Table 3 Valve morphology agreement table between
PTAS CTA and echocardiography
Echocardiography










Table 2 PTAS CTA radiation exposure by tube potential and scan indication
Tube current (mAs) DLP (mGy*cm) CTDIvol (mGy) Scan length (cm) Effective Radiation (mSv)
All exams 218.0 ± 40.2 201.0 [98.3–311.3] 12.9 [6.2–20.7] 17.2 [13.8–20.6] 2.8 [1.4–4.4]
Radiation exposure by tube voltage
80 kV (n = 8) 211.4 ± 42.0 88.0 [85.0–105.5] 6.1 [4.9–6.3] 17.2 [13.8–17.2] 1.2 [1.2–1.5]
100 kV (n = 10) 202.8 ± 36.8 189.0 [140–231] 12.1 [6.8–13.2] 15.6 [13.8–20.6] 2.6 [2.0–3.2]
120 kV (n = 7) 222.1 ± 35.3 298.0 [256.5–385.5] 20.7 [18.2–21.6] 13.8 [13.8–17.3] 4.2 [3.6–5.4]
140 kV (n = 4) 262.0 ± 29.7 768.0 [642.5–872.0] 39.0 [36.3–40.6] 20.7 [17.2–22.4] 10.8 [9.0–12.2]
Radiation exposure by scan indication
Native coronary (n = 19) 225.7 ± 40.1 157.0 [86.0–296.3] 9.9 [6.0–21.1] 13.8 [13.8–17.2] 2.2 [1.2–4.1]
Bypass graft (n = 3) 232.0 ± 17.1 713.0 [319.3–869.0] 34.5 [22.2–37.2] 20.7 [12.9–23.3] 10.0 [4.5–12.2]
Aorta (n = 5) 183.2 ± 35.1 231.0 [202.3–292.5] 13.2 [9.8–15.1] 20.6 [17.3–20.7] 3.2 [2.8–4.1]
Pre-TAVI (n = 2) 211.0 ± 53.7 180 [90–270] 8.7 [4.3–13.0] 20.7 [ 20.7–20.7] 2.5 [1.3–3.8]
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Two readers each with 4 years each of advanced train-
ing (2 years of echocardiography and 2 additional
years of cardiac CT fellowships) were blinded to CTA
and echocardiography results. Readers reviewed im-
ages in consensus and assessed aortic valve morph-
ology and AS. The aortic valve was assessed as 1)
tricuspid, 2) bicuspid, or 3) prosthetic. Confidence in
their assessment was graded on a 4-point Likert scale
(1 = not at all, 2 = somewhat, 3 = confident, 4 = very
confident). Aortic valve orifice area was measured for
each available phase [2,11]. The maximum area was
used to grade potential AS (no evidence of severe AS
vs. severe AS [area less than 1 cm2 by planimetry])
[2,4]. If severe AS could be excluded, confidence was
graded in a similar 4-point Likert scale. Clinical echo-
cardiography reports were independently reviewed by
a research fellow. In echocardiography, aortic valve
area was evaluated by the continuity equation with
valve area less than 1 cm2 considered severe stenosis.
Agreement tables between PTAS CTA and echocardi-
ography were compared.
Statistical analysis
Parametric variables were expressed in mean ± standard
deviation. Non-parametric variables were expressed in
median and interquartile range (IQR). Categorical vari-
ables were expressed as percentages. The accuracy of
PTAS CTA was calculated by (number of cases with re-
sult agreement between CTA and echocardiography) /
(total number of cases evaluable by echocardiography).
Technical results
Of these 29 patients, most (19/29) were referred for
native coronary assessment (Table 1). The mean heart
rate was 66.4 ± 10.9 beats per minute (bpm) andaverage heart rate variability (maximum heart rate–
minimum heart rate) was 39.9 ± 35.6 bpm. Table 1 lists
detailed patient characteristic and scan parameters.
All PTAS CTAs were clinically diagnostic with 0 un-
evaluable coronary and bypass segments with respect to
motion artifact. The average effective dose was 2.8
[1.4–4.4] mSv for all scans. Refer to Table 2 for detailed
radiation parameters by tube potential and scan
indication.
The accuracy of PTAS CTA in assessment of aortic
valve morphology was 92.6% versus echocardiography
(Table 3, Figures 2 and 3, Additional file 1), with a
reader confidence of 3.2 ± 1.1 (confident).
The accuracy of PTAS CTA to exclude severe AS was
93.1% versus echocardiography (Tables 4 and 5), with a
reader confidence of 3.4 ± 1.1 (between confident and
very confident).
Reasons for low confidence were similar for aortic
valve morphology and AS assessment, such as that the
aortic valve remained in closed position throughout all
phases (n = 2 for both), motion artifact (n = 1 for valve
morphology, n = 2 for AS assessment), high image noise
(n = 1 for both), and poor contrast opacification (n = 1
for both).
Figure 2 Bicuspid aortic valve. The cine clip (Additional file 1) shows the open valve (A, C) at 250 mm and closed valve (B, D) at 400 msec.
Curved MPR of the normal LAD without stenosis (E).
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We evaluated the feasibility of a novel protocol to allow
prospectively ECG-triggered cardiac CT angiography
targeted to systolic phases for secondary evaluation of
aortic valvular pathology. We demonstrated that when
adequate phases of the R-R interval were available, the
aortic valve could be evaluated with low radiation doses
(2.8 [1.4–4.4] mSv). An important caveat in this analysis
is that patients were referred primarily for coronary ar-
terial or bypass graft (n = 21) and aortic root or annulus
(n = 5) evaluation (with fully diagnostic results for all
primary indications).
PTAS CTA was initially described as a means of lim-
iting radiation dose in the setting of heart rate irregu-
larity [16-18]. Previously, Feuchtner et al demonstrated
the feasibility of assessing valvular function and
morphology in patients with stable sinus rhythm. How-
ever, we note that in that study, only patients with high
heart rate (>65 bpm) received systolic triggered examsFigure 3 Example of PTAS CTA in aortic valve evaluation. A: Reconstru
aortic valve in open and closed positions. There is mild restriction of the no
stenosis. No motion artifacts were seen in the coronary arteries (not shownwith widened window acquisition (patients with low
heart rate underwent diastolic triggered exams). In
addition, those CTAs were performed with additional
20% mAs exposure during 10–90% of the cardiac cycle.
In our present study, the widened acquisition window
with 20% mAs exposure was only used from 200 to
450 msec after the R peak, or approximately 20%–50%
of the cardiac cycle for patients with a heart rate of
66 bpm (the average heart rate in our cohort). There-
fore, while Feuchtner et al showed accurate aortic as-
sessment with 20% mAs exposure during nearly the
entire cardiac cycle, we demonstrated that systolic
phase image acquisition with a 250 msec acquisition
window may be sufficient for aortic assessment.
The two most effective methods of cardiac CT dose
reduction are the use of prospective triggering and
tube potential lowering [13,14,22]. Traditionally, pro-
spectively triggered CTAs were prone to motion or
misregistration artifacts caused by irregular heartctions at 250 msec (top row) and 400 msec (bottom row) show the
n-coronary cusp opening (arrows). B: Planimetry shows mild aortic
).


















Table 5 Overall performance of PTAS CTA on aortic valve
evaluation
Accuracy Confidence
Valve morphology 92.6% 3.2 ± 1.1
Severe aortic stenosis 93.1% 3.4 ± 1.1
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tive contraindication to CTA due to high radiation
exposure and image quality concerns [23]. This chal-
lenge posed by elevated and irregular heart rates and
rhythms has been progressively addressed by techno-
logic developments such as arrhythmia rejection algo-
rithms [16] and systolic triggering [17].
In addition to prospective ECG triggering, we im-
plemented automatic kVp selection to minimize tube
voltage and concomitantly adjust tube current to pre-
serve the necessary photon flux [20,21]. Some cases
involved higher kV settings due to large patients and
longer scans of the entire chest since the scans were
not clinically performed for aortic valve assessment.
Concurrent assessment of aortic valve by PTAS CTA
in addition to coronary assessment carries several clin-
ical advantages. If aortic valve pathology is unknown or
unexpected, obvious benefits can be realized through
early diagnosis. In cases of thoracic aortic evaluation,
the questions of aortic valve morphology (such as bi-
cuspid versus tricuspid) might be addressed, thereby
obviating transesophageal echocardiography in some
cases. In the setting of known aortic valvular disease
(such as in percutaneous aortic valve implantation
planning CTA), a PTAS protocol can allow concurrent
valvular assessment and coronary artery stenosis exclu-
sion. This could obviate the need for preoperative inva-
sive coronary angiography (acknowledging that these
are older, higher risk patients than traditional CTA pa-
tients), and potentially obviate the need for pre-
procedural transesophageal echocardiography. While
the traditional assessment of the significance of aortic
stenosis is by Doppler evaluation, direct planimetry is
performed by transesophageal echocardiography; this
can be assessed by CTA [10].
Our retrospective cohort study carries several limita-
tions precisely because patients were referred for other
indications than primary aortic valve assessment. While
images were sufficient for the clinically requested cor-
onary or aortic vascular assessment in all cases, insuffi-
cient aortic valvular phase images were archived in 2
cases. In addition, although adequate imaging may have
been initially acquired for aortic valve analysis, not allnecessary phases were available for interpretation in
our study (i.e. were not archived). Second, we utilized a
second-generation dual-source scanner, with the most
current software upgrade. Other scanners have been
used for aortic valve imaging, but may not have avail-
able similar settings such as prospective triggering op-
tions with positive absolute phase start times or high
temporal resolution [19]. Other equipment therefore
may require different triggering settings or require lon-
ger acquisitions and larger radiation doses. Our method
therefore warrants dedicated confirmatory study in a
larger cohort on this specific scanner, and exploratory
study using other scanner models which offer prospect-
ive ECG triggering.Conclusion
We demonstrated feasibility of a prospectively ECG-
triggered cardiac CT angiography targeted to end-systole
for the evaluation of aortic pathology at a low radiation
dose (2.8 mSv) with echocardiography as the reference
standard. This is significantly lower than previously
reported retrospectively ECG-gated modes (6.7 to 20 mSv).
We note that care must be taken to reconstruct sufficient
phase reconstructions to completely evaluate the aortic
valve. Our results suggest that further study in a larger co-
hort should be performed to confirm our favorable results
and to ensure the maintained diagnostic capacity of native
coronary arteries.Consent
Our institutional IRB (The Partners Human Research
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